Meeting
2017 Genitourinary Cancers Symposium
Outcomes and predictors of survival in testicular sarcomas.
Authors
Samer Alsidawi
Mayo Clinic, Rochester, MN
Samer Alsidawi , Gustavo Figueiredo Marcondes Westin , Scott H. Okuno
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer
Track
Renal Cell Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Penile, Urethral, and Testicular Cancers
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 404)
DOI
10.1200/JCO.2017.35.6_suppl.404
Abstract #
404
Poster Bd #
B21
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Early circulating tumor DNA (ctDNA) changes during treatment with immune checkpoint inhibitors (ICI) as a predictor of clinical outcomes in patients (pts) with advanced stage melanoma/skin cancer.
First Author: Vincent T. Ma
Poster
2024 ASCO Annual Meeting
Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma.
First Author: Kelsey Klute
Poster
2023 ASCO Annual Meeting
Association of 18F-FDG PET characteristics and survival outcomes using whole body tumor analysis in patients (pts) with metastatic genitourinary (GU) malignancies.
First Author: Nicholas I. Simon
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Nab-paclitaxel combined with oxaliplatin and S-1 as conversion therapy for advanced gastric adenocarcinoma.
First Author: Ke Ji